TVRD
Tvardi Therapeutics, Inc.
$3.28
-0.52 (-13.68%)
At close · Jul 10
Market Cap
$30.77M
Shares
9,381,344
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-07 | — | |
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-11 | 2026-06-09 | |
| 8-K | 2026-05-08 | — | |
| 10-Q | 2026-05-08 | 2026-03-31 | |
| DEF 14A | 2026-04-23 | 2026-06-09 | |
| 10-K | 2026-03-31 | 2025-12-31 | |
| 8-K | 2026-03-31 | — | |
| 8-K | 2026-03-06 | — | |
| 8-K | 2026-01-16 | — | |
| 8-K | 2025-12-18 | 2025-12-16 | |
| 8-K | 2025-11-19 | — | |
| 10-Q | 2025-11-13 | 2025-09-30 | |
| 8-K | 2025-11-13 | — | |
| 8-K | 2025-10-14 | 2025-10-13 | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-08-14 | — | |
| 8-K | 2025-07-14 | 2025-07-08 | |
| 8-K | 2025-06-09 | 2025-06-06 | |
| 8-K | 2025-05-27 | — | |
| 8-K | 2025-05-13 | 2025-05-12 | |
| 8-K/A | 2025-05-13 | 2025-04-15 | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| 8-K | 2025-04-15 | — | |
| 8-K | 2025-04-11 | — | |
| 8-K | 2025-04-01 | — | |
| 8-K | 2025-03-24 | — | |
| 10-K | 2025-03-11 | 2024-12-31 | |
| 8-K | 2025-01-21 | 2025-01-16 | |
| 8-K | 2025-01-17 | 2025-01-14 | |
| 8-K | 2024-12-30 | — | |
| 8-K/A | 2024-12-20 | 2024-12-17 | |
| 8-K | 2024-12-18 | 2024-12-17 | |
| 8-K | 2024-11-22 | 2024-11-19 | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 8-K | 2024-08-01 | 2024-07-31 | |
| 8-K | 2024-06-18 | 2024-06-14 | |
| 8-K | 2024-06-12 | — | |
| 8-K | 2024-06-07 | 2024-06-04 | |
| 10-Q | 2024-05-13 | 2024-03-31 | |
| 8-K | 2024-05-13 | — | |
| DEF 14A | 2024-04-22 | 2024-06-04 | |
| 8-K | 2024-03-22 | 2024-03-19 | |
| 10-K | 2024-03-06 | 2023-12-31 | |
| 8-K | 2024-03-04 | — | |
| 8-K | 2024-02-02 | 2024-02-01 | |
| 8-K | 2024-01-22 | 2024-01-17 | |
| 8-K | 2023-12-18 | — | |
| 8-K | 2023-11-13 | — |
Showing 1–50 of 124 filings